Compare Stocks → RE: Your account status (From MarketBeat) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDigital Media StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:AFIBNASDAQ:BJDXNASDAQ:NMRDNASDAQ:SINT Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAFIBAcutus Medical$0.05$0.13$0.04▼$0.99$1.43M0.251.65 million shs537,665 shsBJDXBluejay Diagnostics$0.53$0.60$0.39▼$13.98$1.43M0.9850,742 shs13,214 shsNMRDNemaura Medical$0.05$0.06$0.03▼$1.25$1.96M0.0476,908 shs2,904 shsSINTSintx Technologies$7.25-6.1%$9.81$4.12▼$364.00$4.42M1.39216,308 shs116,007 shs10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAFIBAcutus Medical+12.17%-8.99%-67.99%-77.16%-94.35%BJDXBluejay Diagnostics+6.00%+2.91%+8.16%-35.37%-88.79%NMRDNemaura Medical+2.00%-8.18%-23.21%-42.50%-90.78%SINTSintx Technologies-1.28%-51.81%-14.98%-72.29%-97.37%Tech GIANT’s Plans to Revolutionize Crypto… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAFIBAcutus MedicalN/AN/AN/AN/AN/AN/AN/AN/ABJDXBluejay DiagnosticsN/AN/AN/AN/AN/AN/AN/AN/ANMRDNemaura Medical1.4723 of 5 stars3.50.00.04.50.01.70.0SINTSintx TechnologiesN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAFIBAcutus MedicalN/AN/AN/AN/ABJDXBluejay Diagnostics2.00HoldN/AN/ANMRDNemaura Medical3.00Buy$2.505,059.96% UpsideSINTSintx Technologies2.00HoldN/AN/ACurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAFIBAcutus Medical$7.16M0.20N/AN/A($0.14) per share-0.34BJDXBluejay Diagnostics$250K5.70N/AN/A$1.25 per share0.42NMRDNemaura Medical$80K24.44N/AN/A($0.41) per share-0.12SINTSintx Technologies$2.63M1.68N/AN/A$16.18 per share0.45Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAFIBAcutus Medical-$81.66MN/A0.00∞N/A-166.79%-54.97%-13.82%N/ABJDXBluejay Diagnostics-$9.95M-$9.01N/A∞N/AN/A-218.30%-146.12%6/5/2024 (Estimated)NMRDNemaura Medical-$14.14M-$0.39N/A∞N/AN/AN/A-142.69%N/ASINTSintx Technologies-$8.26M-$358.00N/A∞N/A-318.99%-81.96%-52.43%8/13/2024 (Estimated)Latest NMRD, SINT, AFIB, and BJDX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/9/2024Q1 2024AFIBAcutus MedicalN/A-$0.07-$0.07-$0.08N/A$3.63 million3/28/2024Q4 2023BJDXBluejay Diagnostics-$0.68-$1.78-$1.10-$1.78N/AN/A3/27/2024Q4 2023SINTSintx TechnologiesN/A-$18.00-$18.00-$0.09N/A$0.90 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAFIBAcutus MedicalN/AN/AN/AN/AN/ABJDXBluejay DiagnosticsN/AN/AN/AN/AN/ANMRDNemaura MedicalN/AN/AN/AN/AN/ASINTSintx TechnologiesN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAFIBAcutus Medical1.103.482.89BJDXBluejay DiagnosticsN/A2.262.26NMRDNemaura MedicalN/A0.190.03SINTSintx TechnologiesN/A1.841.67OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAFIBAcutus Medical56.91%BJDXBluejay Diagnostics18.47%NMRDNemaura Medical4.41%SINTSintx Technologies18.38%Insider OwnershipCompanyInsider OwnershipAFIBAcutus Medical5.21%BJDXBluejay Diagnostics17.60%NMRDNemaura Medical41.60%SINTSintx Technologies1.00%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableAFIBAcutus Medical23029.72 million28.17 millionOptionableBJDXBluejay Diagnostics102.69 million2.22 millionNot OptionableNMRDNemaura Medical3640.35 million23.57 millionOptionableSINTSintx Technologies43610,000607,000Not OptionableNMRD, SINT, AFIB, and BJDX HeadlinesRecent News About These CompaniesMay 30 at 7:06 AM | americanbankingnews.comSintx Technologies (NASDAQ:SINT) Shares Gap Down to $13.52May 29 at 1:56 PM | marketbeat.comSintx Technologies (NASDAQ:SINT) Trading Down 8.5%May 29 at 12:18 PM | finance.yahoo.comSINTX TECHNOLOGIES SIGNS AGREEMENT TO ENTER KOREAN TECHNICAL CERAMICS SECTORMay 28 at 4:49 PM | marketbeat.comShort Interest in Sintx Technologies, Inc. (NASDAQ:SINT) Decreases By 78.8%May 28 at 3:02 PM | marketwatch.comSiNtx Technologies Down 39% After Reverse SplitMay 24, 2024 | msn.comWhy SINTX Technologies Stock Is FallingMay 24, 2024 | americanbankingnews.comSintx Technologies (NASDAQ:SINT) Shares Scheduled to Reverse Split on Tuesday, May 28thMay 23, 2024 | globenewswire.comSINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE MAY 28, 2024May 21, 2024 | americanbankingnews.comSintx Technologies (NASDAQ:SINT) Trading Up 32.8%May 17, 2024 | uk.finance.yahoo.comSintx Technologies, Inc. (0A8S.L)May 15, 2024 | bovnews.comSINTX Technologies Inc (SINT) Stock is poised for a successful quarterMay 15, 2024 | msn.comWhy SiNtx Technologies Stock Is SoaringMay 15, 2024 | msn.comWhy Is Sintx Technologies (SINT) Stock Up 113% Today?May 14, 2024 | msn.comSINT Stock Earnings: SINTX Technologies Misses EPS, Misses Revenue for Q1 2024April 30, 2024 | tctmagazine.comProdways & SINTX announce deep technical ceramic 3D printing partnershipApril 29, 2024 | msn.comWhy SINTX Technologies Shares Are SkyrocketingApril 29, 2024 | globenewswire.comSINTX AND PRODWAYS AGREE ON CERAMIC SLURRY SUPPLY AND 3D PRINTING AGREEMENTApril 3, 2024 | msn.comWhy SINTX Technologies Stock Is Getting HammeredApril 3, 2024 | globenewswire.comSINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common StockApril 1, 2024 | msn.comWhy SINTX Technologies Stock Hit A New All-Time Low TodayMarch 30, 2024 | itnewsonline.comDDC Appoints Vice President to Drive Operational ExcellenceNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsAcutus MedicalNASDAQ:AFIBAcutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.Bluejay DiagnosticsNASDAQ:BJDXBluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.Nemaura MedicalNASDAQ:NMRDNemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.Sintx TechnologiesNASDAQ:SINTSintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
